EULAC-PerMed has been funded by the

European Union’s Horizon 2020

Research and Innovation Programme

under Grant Agreement (GA) No 825173

Esther Rodríguez, PhDHead of European Project OfficeInstituto de Salud Carlos III Montevideo, December 2019

Project Overview

Research on Personalized Medicine (PerMed) is a top priority for the European Union (EU) as a strategy aimed at delivering personalised health and care

solutions to benefit citizens.

Investment & Alignment

• Council conclusions on personalised medicine for patients, published in December 2015.

• International Consortium forPersonalized Medicine (ICPerMed) since Nov. 2016

• ERAPerMed ERANET forPersonalized Medicine sinceDec. 2017

• + several Coordination & Support Actions

EULAC PerMed as part of the ICPerMedFamily

EULAC PerMed

In order to strengthen the global efforts on Personalized Medicine and the cooperation of

Europe (EU) with Latin American and Caribbean (LAC) countries , the EULAC

PerMed project, funded by the Horizon 2020 Programme of the European Commission, has

been launched in January 2019

EULAC PerMed has the ambition to engage LAC countries in the International

Consortium on Personalized Medicine (ICPerMed) and in the

ERANet ERAPerMed with the aim at advancing in the implementation of the

Action Plan of ICPerMed.

SPECIFIC OBJECTIVES

• EULAC PerMed will be the vehicle for:

• Mapping existing programmes, capacities and expertise and gaps in CELAC countries. (WP2)

• Facilitating the incorporation of LAC countries in ICPerMed and in the ERAPerMed. (WP3)

• Fostering the participation of LAC countries in research mobility and transnational projects on PerMed, and a platform for EU‐LAC collaboration on clinical trials PerMed focused. (WP4)

• Cross-border learning from Research and Innovation and the ethical, legal and social aspects for implementing innovations between research capacities based in EU and LAC. (WP5)

ES WP1

PA ES WP2

SGCTeIP AR DE WP3

UY IT WP4

BR EU/FR WP5

CL IL WP6

A birregional Consortium

+Associated Partners

Associated Partner Country

CONACYT - Consejo Nacional de Ciencia y Tecnología Paraguay

MINEDU - Ministerio de Educación Bolivia

LANOTEC-CeNAT - Laboratorio Nacional de Nanotecnología Costa Rica

SENACYT - Secretaría Nacional de Ciencia y Tecnología Guatemala

VTT - Technical Research Centre of Finland Ltd Finland

Ministerio de Salud Panamá

Implementation

EXPECTED IMPACT

Contributing to the success and long-term impact of PerMed

Research activities promoted in the framework of IC PerMed

enabling a wider/international engagement in PM, faster

uptake of results, and alignment and adoption of common

standards in the regions thanks to COOPERATION

http://www.eulac-permed.eu/

@EULACPerMed

https://www.linkedin.com/in/eulac-permed-project/